Julie Lonjon
Impact in
- Hepatology top 1%
- Hepatocellular Carcinoma Treatment and Prognosis
- Liver Disease and Transplantation
-
- Liver Disease Diagnosis and Treatment
- Hepatitis B Virus Studies
Papers in
-
- Hepatocellular Carcinoma Treatment and Prognosis 7
- Surgery 3
- Spinal Hematomas and Complications 1
- Abdominal vascular conditions and treatments 1
- Colorectal and Anal Carcinomas 1
- Co-authors
- Christophe Cassinotto (2 shared papers)Maxime Ronot (2 shared papers)G. Nkontchou (1 shared paper)Olivier Séror (2 shared papers)Julien Vergniol (1 shared paper)Valérie Vilgrain (2 shared papers)Agnès Rode (3 shared papers)Laurent Castéra (1 shared paper)
In The Last Decade
Julie Lonjon
10 papers receiving 802 citations
Julie Lonjon's Hit Papers
Peers
Comparison fields: 5 of 48
- Hepatology 672
- Epidemiology 202
- Pathology and Forensic Medicine 72
- Cancer Research 58
- Pulmonary and Respiratory Medicine 105
Countries citing papers authored by Julie Lonjon
This map shows the geographic impact of Julie Lonjon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Julie Lonjon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Julie Lonjon more than expected).
Fields of papers citing papers by Julie Lonjon
This network shows the impact of papers produced by Julie Lonjon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Julie Lonjon. The network helps show where Julie Lonjon may publish in the future.
Co-authors
The 25 scholars most cited alongside Julie Lonjon, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Efficacy and safety of selective internal radiotherapy with yttrium-90 resin microspheres compared with sorafenib in locally advanced and inoperable hepatocellular carcinoma (SARAH): an open-label randomised controlled phase 3 trial Hit paper breakdown → | 2017 | 653 |
| 2 | 2017 | 106 | |
| 3 | 2021 | 15 | |
| 4 | 2020 | 12 | |
| 5 | 2014 | 11 | |
| 6 | 2008 | 6 | |
| 7 | 2011 | 5 | |
| 8 | 2021 | 5 | |
| 9 | 2023 | 5 | |
| 10 | 2019 | 1 |
About Julie Lonjon
Julie Lonjon is a scholar working on Hepatology, Surgery, Emergency Medicine, Rheumatology and Neurology, having authored 10 papers that have together received 819 indexed citations. Recurring topics across this work include Hepatocellular Carcinoma Treatment and Prognosis (7 papers), Spinal Hematomas and Complications (1 paper), Abdominal vascular conditions and treatments (1 paper), Radiomics and Machine Learning in Medical Imaging (1 paper), Appendicitis Diagnosis and Management (1 paper), Colorectal Cancer Surgical Treatments (1 paper), Colorectal and Anal Carcinomas (1 paper) and Intracranial Aneurysms: Treatment and Complications (1 paper). The work is most often cited by research in Hepatology (672 citations), Epidemiology (202 citations), Pathology and Forensic Medicine (72 citations), Cancer Research (58 citations) and Pulmonary and Respiratory Medicine (105 citations). Julie Lonjon has collaborated with scholars based in France, India and Canada. Frequent co-authors include Christophe Cassinotto, Maxime Ronot, G. Nkontchou, Olivier Séror, Julien Vergniol, Valérie Vilgrain, Agnès Rode, Laurent Castéra, Christophe Aube and Georges‐Philippe Pageaux. Their work appears in journals such as Diagnostic and Interventional Imaging, European Journal of Gastroenterology & Hepatology, Clinical Therapeutics, Liver International and Journal of Neuroradiology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.